Subtopic Deep Dive

Echinocandin Resistance in Candida glabrata
Research Guide

What is Echinocandin Resistance in Candida glabrata?

Echinocandin resistance in Candida glabrata refers to reduced susceptibility to echinocandin antifungals caused primarily by mutations in FKS1 and FKS2 genes encoding glucan synthase.

Candida glabrata ranks as the second most common cause of candidemia with rising echinocandin resistance rates. FKS mutations correlate with elevated MICs and clinical treatment failure (Alexander et al., 2013, 760 citations). Prevalence in bloodstream infections exceeds 10% in some surveillance studies.

15
Curated Papers
3
Key Challenges

Why It Matters

Echinocandin resistance in C. glabrata compromises first-line therapy for invasive candidiasis, increasing mortality in ICU patients with candidemia (Pappas et al., 2009, 3192 citations). Alexander et al. (2013) documented clinical failures linked to FKS mutations and high MICs. This drives demand for rapid diagnostics and alternative agents amid limited antifungal options (Fisher et al., 2022, 993 citations).

Key Research Challenges

Detecting FKS Mutations

Sequencing FKS1/FKS2 hotspots remains labor-intensive for routine surveillance. Alexander et al. (2013) showed mutations predict echinocandin failure but PCR assays vary in sensitivity. Standardization lags behind bacterial diagnostics.

Tracking Prevalence Trends

Resistance rates vary by geography and hospital, complicating global surveillance. Pappas et al. (2018) noted rising C. glabrata echinocandin resistance in candidemia cohorts. Multi-center data integration faces methodological inconsistencies.

Developing Alternatives

Few novel antifungals target glucan synthase bypass mechanisms. Cowen et al. (2014, 597 citations) outlined efflux and target alteration as barriers. Clinical trials for C. glabrata-specific agents remain scarce.

Essential Papers

1.

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Peter G. Pappas, Carol A. Kauffman, David R. Andes et al. · 2009 · Clinical Infectious Diseases · 3.2K citations

Abstract Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated gu...

2.

Invasive candidiasis

Peter G. Pappas, Michail S. Lionakis, Maiken Cavling Arendrup et al. · 2018 · Nature Reviews Disease Primers · 1.4K citations

3.

Tackling the emerging threat of antifungal resistance to human health

Matthew C. Fisher, Ana Alastruey‐Izquierdo, Judith Berman et al. · 2022 · Nature Reviews Microbiology · 993 citations

4.

The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species

Rocio Garcia‐Rubio, Haroldo César de Oliveira, Johanna Rivera et al. · 2020 · Frontiers in Microbiology · 820 citations

The fungal cell wall is located outside the plasma membrane and is the cell compartment that mediates all the relationships of the cell with the environment. It protects the contents of the cell, g...

5.

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Barbara D. Alexander, Melissa D. Johnson, Christopher D. Pfeiffer et al. · 2013 · Clinical Infectious Diseases · 760 citations

Echinocandin resistance is increasing, including among FLC-resistant isolates. The new Clinical and Laboratory Standards Institute clinical breakpoints differentiate wild-type from C. glabrata stra...

6.

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

Anuradha Chowdhary, Cheshta Sharma, Jacques F. Meis · 2017 · PLoS Pathogens · 699 citations

Candidiasis, which includes both superficial infections and invasive disease, is the most common cause of fungal infection worldwide.Candida bloodstream infections (BSI) cause significant mortality...

7.

Resistance to Antifungal Agents: Mechanisms and Clinical Impact

Zeina A. Kanafani, John R. Perfect · 2007 · Clinical Infectious Diseases · 613 citations

Despite advances in preventive, diagnostic, and therapeutic interventions, invasive fungal infections cause significant morbidity and mortality in immunocompromised patients. The burden of antifung...

Reading Guide

Foundational Papers

Start with Pappas et al. (2009, 3192 citations) for candidiasis management baselines, then Alexander et al. (2013, 760 citations) for FKS-clinical correlations establishing resistance mechanisms.

Recent Advances

Study Fisher et al. (2022, 993 citations) for global threats and Pappas et al. (2018, 1388 citations) for updated candidiasis epidemiology.

Core Methods

FKS hotspot sequencing, CLSI MIC testing, and surveillance via EUCAST/CLSI standards (Alexander et al., 2013; Cowen et al., 2014).

How PapersFlow Helps You Research Echinocandin Resistance in Candida glabrata

Discover & Search

Research Agent uses searchPapers('echinocandin resistance Candida glabrata FKS') to retrieve 50+ papers including Alexander et al. (2013), then citationGraph to map FKS mutation clusters from Pappas et al. (2009). findSimilarPapers on Alexander expands to clinical failure cases; exaSearch uncovers surveillance data from Fisher et al. (2022).

Analyze & Verify

Analysis Agent applies readPaperContent to Alexander et al. (2013) extracting FKS mutation MIC correlations, then verifyResponse with CoVe cross-checks against Pappas et al. (2009) guidelines. runPythonAnalysis parses MIC distributions from tables using pandas for statistical outliers; GRADE grading scores evidence as high for clinical failure links.

Synthesize & Write

Synthesis Agent detects gaps in echinocandin alternatives post-FKS resistance via contradiction flagging across Cowen et al. (2014). Writing Agent uses latexEditText for methods sections, latexSyncCitations integrating Alexander (2013), and latexCompile for review drafts; exportMermaid visualizes resistance mechanism diagrams.

Use Cases

"Extract MIC data from echinocandin resistance papers and plot FKS mutant distributions"

Research Agent → searchPapers → Analysis Agent → readPaperContent(Alexander 2013) → runPythonAnalysis(pandas plot MIC histograms) → matplotlib figure of wild-type vs mutant MICs.

"Draft LaTeX review on FKS mutations in C. glabrata with citations"

Research Agent → citationGraph(Pappas 2009) → Synthesis → gap detection → Writing Agent → latexEditText(intro) → latexSyncCitations(Alexander 2013) → latexCompile(PDF review).

"Find code for modeling echinocandin MIC prediction from FKS sequences"

Research Agent → searchPapers(FKS MIC model) → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(test MIC prediction script).

Automated Workflows

Deep Research workflow scans 50+ papers on FKS mutations via searchPapers → citationGraph → structured report ranking Alexander (2013) highest impact. DeepScan's 7-step chain verifies Pappas (2009) guidelines against recent Fisher (2022) threats with CoVe checkpoints. Theorizer generates hypotheses on FKS evolution from Cowen (2014) mechanisms.

Frequently Asked Questions

What defines echinocandin resistance in C. glabrata?

Resistance stems from FKS1/FKS2 mutations raising echinocandin MICs >0.5 μg/mL, per CLSI breakpoints (Alexander et al., 2013).

What methods detect FKS mutations?

PCR sequencing of FKS1 hs1/2 and FKS2 hs1 hotspots identifies resistance; whole-genome sequencing confirms (Cowen et al., 2014).

What are key papers?

Alexander et al. (2013, 760 citations) links FKS mutations to failure; Pappas et al. (2009, 3192 citations) provides candidiasis guidelines.

What open problems exist?

Predicting resistance spread, novel glucan synthase inhibitors, and rapid bedside diagnostics for FKS mutations remain unsolved (Fisher et al., 2022).

Research Antifungal resistance and susceptibility with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching Echinocandin Resistance in Candida glabrata with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.